Benzinga | Aug 5, 2021 05:33PM EDT

ResMed Q4 EPS $1.35 Beats $1.28 Estimate, Sales $876.10M Beat $783.18M Estimate

ResMed (NYSE:RMD) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.28 by 5.47 percent. This is a 1.5 percent increase over earnings of $1.33 per share from the same period last year. The company reported quarterly sales of $876.10 million which beat the analyst consensus estimate of $783.18 million by 11.86 percent. This is a 13.73 percent increase over sales of $770.34 million the same period last year.